Direct Switch From Iptacopan to Pegcetacoplan in a Patient With Paroxysmal Nocturnal Hemoglobinuria

ABSTRACT Introduction Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal hematologic disorder treated with complement inhibitors. Currently, patients with suboptimal response to C5 inhibitors may be switched to proximal complement inhibitors, such as pegcetacoplan, danicopan, or iptacopan. H...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Vitalii Latyshev, Zalina Fidarova, Elena Lukina, Elena Parovichnikova
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2026-04-01
Schriftenreihe:	eJHaem
Schlagworte:	case report complement inhibitor eculizumab iptacopan paroxysmal nocturnal hemoglobinuria pegcetacoplan
Online-Zugang:	https://doi.org/10.1002/jha2.70298
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!